Back to AZN overview
#
AZN Astrazeneca
PE ratio, current and historical analysis

## AZN PE ratio history

### Astrazeneca PE ratio by year

## AZN average PE ratio chart

## AZN PE vs peers

## Frequently asked questions

###
What is Astrazeneca's PE ratio?

###
What is the 3-year average PE ratio for Astrazeneca (AZN)?

###
What is the 5-year average PE ratio for Astrazeneca (AZN)?

###
What is the highest PE ratio for AZN?

###
How does the current PE ratio for AZN compare to its historical average?

###
How is AZN's PE ratio calculated (Astrazeneca PE ratio formula)?

The current PE ratio for Astrazeneca stock as of Jun 20, 2024 is 38.32. This is calculated based on the TTM EPS of $2.05 and the stock price of $78.56 per share. The PE ratio marks an increase of 10% from its last 4 quarters average of 34.9.

How has AZN's PE ratio performed in the past

The average historical PE ratio of Astrazeneca for the last ten years is 85.02. The current P/E ratio of 38.32 is 55% lower than the historical average. Looking back at the last ten years, AZN's PE ratio peaked in the Dec 2021 quarter at 1,456.25, when the price was $58.25 and the EPS was $0.04. The lowest point was in the Dec 2016 quarter, when it reached 19.65 with a price of $27.32 and an EPS of $1.39.

Average

85.02

Median

42.08

Minimum

19.65

Maximum

1,456.25

Maximum annual increase: 3,453.56% in 2021

Maximum annual decrease: -95.61% in 2022

Year | PE ratio | Change |
---|---|---|

2023 | 35.08 | -45.15% |

2022 | 63.96 | -95.61% |

2021 | 1,456.25 | 3,453.56% |

2020 | 40.98 | -57.26% |

2019 | 95.88 | 114.59% |

2018 | 44.68 | 53.22% |

2017 | 29.16 | 48.4% |

2016 | 19.65 | -35.17% |

2015 | 30.31 | -57.8% |

2014 | 71.82 | 146.8% |

What is the average PE ratio of AZN for the past years

Currently, AZN's PE ratio is lower than its 3, 5 and 10-year averages.

3-year avg

193.74

5-year avg

133.84

10-year avg

85.02

15-year avg

59.65

What is AZN's PE ratio compared to its peers

In comparison to its peers LLY and MRK, AZN's PE ratio is lower, but it is higher than JNJ's and NVS's. Astrazeneca's PE ratio is trading above the peer average of 21.24.

Stock name | PE ratio | Market cap |
---|---|---|

JNJ Johnson & Johnson | 9.75 | $357.99B |

NVS Novartis AG | 14.2 | $214.69B |

BIIB Biogen Inc | 27.85 | $32.64B |

ABT Abbott Laboratories | 32.73 | $183.91B |

AZN Astrazeneca plc | 38.48 | $244.55B |

LLY ELI LILLY & Co | 129.6 | $840.04B |

MRK Merck & Co Inc | 143.65 | $331.09B |

PFE Pfizer Inc | N/A | $157.19B |

BMY Bristol Myers Squibb Co | N/A | $85B |

AZN stock has a price to earnings ratio of 38.32 as of Jun 20, 2024.

The 3-year average price to earnings ratio for AZN stock is 193.74.

The 5-year average price to earnings ratio for AZN stock is 133.84.

Over the last ten years, the quarterly PE ratio reached its highest level at 1,456.25 in the Dec 2021 quarter.

The current PE ratio of AZN is 55% lower than the 10-year historical average.

You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 20, 2024), Astrazeneca's share price is $78.56. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.05. Therefore, Astrazeneca's PE ratio for today is 38.32. `PE RATIO(38.32) = STOCK PRICE($78.56) / TTM EPS($2.05)`

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.